Citius Oncology, Inc. (CTOR) — Defensive Interval Ratio
Latest as of March 2026:
7 days
Citius Oncology, Inc. (CTOR) has a Defensive Interval Ratio of 7 days as of March 2026. Defensive assets of $1.08 Million (cash $-, short-term investments $-, receivables $1.08 Million) cover 7 days of daily cash needs of $161.13K/day.
Defensive Interval Ratio
7 days
Days of operational coverage
Defensive Assets
$1.08 Million
Cash + ST Investments + Receivables
Daily Cash Need
$161.13K
Current Liabilities ÷ 365
Current Liabilities
$58.81 Million
USD
Annual Defensive Interval Ratio for Citius Oncology, Inc. (None–None)
The table below presents the year-by-year Defensive Interval Ratio for Citius Oncology, Inc. from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Citius Oncology, Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)